These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 24704314

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Co-localization of glycogen synthase kinase-3 with neurofibrillary tangles and granulovacuolar degeneration in transgenic mice.
    Ishizawa T, Sahara N, Ishiguro K, Kersh J, McGowan E, Lewis J, Hutton M, Dickson DW, Yen SH.
    Am J Pathol; 2003 Sep; 163(3):1057-67. PubMed ID: 12937146
    [Abstract] [Full Text] [Related]

  • 6. Amyloid activates GSK-3beta to aggravate neuronal tauopathy in bigenic mice.
    Terwel D, Muyllaert D, Dewachter I, Borghgraef P, Croes S, Devijver H, Van Leuven F.
    Am J Pathol; 2008 Mar; 172(3):786-98. PubMed ID: 18258852
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Split GFP complementation assay: a novel approach to quantitatively measure aggregation of tau in situ: effects of GSK3beta activation and caspase 3 cleavage.
    Chun W, Waldo GS, Johnson GV.
    J Neurochem; 2007 Dec; 103(6):2529-39. PubMed ID: 17908237
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Tau phosphorylation and kinase activation in familial tauopathy linked to deln296 mutation.
    Ferrer I, Pastor P, Rey MJ, Muñoz E, Puig B, Pastor E, Oliva R, Tolosa E.
    Neuropathol Appl Neurobiol; 2003 Feb; 29(1):23-34. PubMed ID: 12581337
    [Abstract] [Full Text] [Related]

  • 13. Transgenic mouse models for Alzheimer's disease: the role of GSK-3B in combined amyloid and tau-pathology.
    Muyllaert D, Terwel D, Borghgraef P, Devijver H, Dewachter I, Van Leuven F.
    Rev Neurol (Paris); 2006 Oct; 162(10):903-7. PubMed ID: 17028556
    [Abstract] [Full Text] [Related]

  • 14. Age-related impairment of ultrasonic vocalization in Tau.P301L mice: possible implication for progressive language disorders.
    Menuet C, Cazals Y, Gestreau C, Borghgraef P, Gielis L, Dutschmann M, Van Leuven F, Hilaire G.
    PLoS One; 2011 Oct; 6(10):e25770. PubMed ID: 22022446
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Tau Fibril Formation in Cultured Cells Compatible with a Mouse Model of Tauopathy.
    Matsumoto G, Matsumoto K, Kimura T, Suhara T, Higuchi M, Sahara N, Mori N.
    Int J Mol Sci; 2018 May 17; 19(5):. PubMed ID: 29772786
    [Abstract] [Full Text] [Related]

  • 17. IFN-γ promotes τ phosphorylation without affecting mature tangles.
    Li A, Ceballos-Diaz C, DiNunno N, Levites Y, Cruz PE, Lewis J, Golde TE, Chakrabarty P.
    FASEB J; 2015 Oct 17; 29(10):4384-98. PubMed ID: 26156074
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Increase in tau tyrosine phosphorylation correlates with the formation of tau aggregates.
    Vega IE, Cui L, Propst JA, Hutton ML, Lee G, Yen SH.
    Brain Res Mol Brain Res; 2005 Aug 18; 138(2):135-44. PubMed ID: 15913839
    [Abstract] [Full Text] [Related]

  • 20. Temsirolimus attenuates tauopathy in vitro and in vivo by targeting tau hyperphosphorylation and autophagic clearance.
    Jiang T, Yu JT, Zhu XC, Zhang QQ, Cao L, Wang HF, Tan MS, Gao Q, Qin H, Zhang YD, Tan L.
    Neuropharmacology; 2014 Oct 18; 85():121-30. PubMed ID: 24880087
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.